Across TCGA pan-cancer cohorts, CCDC152 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CCDC152 data layer compared with 26 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CCDC152 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated CCDC152 expression acts as an unfavorable survival marker, although some lineages such as UCEC and BLCA show a favorable association.

UCEC, SCLC, and BLCA are the cancer types where CCDC152 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.627	.014	20	view →
SCLC	DFS	Median	II,III,IV	0.137	0.562	.013	12	view →
BLCA	DFS	Median	IV	1.000	0.197	.049	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: CCDC152 tumor-vs-normal RNA expression · all CCDC152 data types